Advisers to the Food and Drug Administration are meeting to review a gene therapy technique called CRISPR to treat sickle cell disease.

Share:
More In Science
RoadRunner Raises $70 Million Series D to Fund National Expansion and Accelerate Sustainability Solutions
Technology-driven sustainable waste management platform, RoadRunner Recycling, recently raised a $70 million Series D round from BeyondNetZero, the climate investing venture of General Atlantic. RoadRunner says it creates and manages end-to-end waste and recycling solutions for businesses of all sizes and that its proprietary technology can boost cost savings and improve recycling rates for companies, which in turn drives sustainability for the waste industry and our world. RoadRunner Recycling founder and CEO Graham Rihn joined Cheddar News' Closing Bell to discuss.
Load More